Gralnek, I M <br/><br/>
The economic impact of esophageal variceal hemorrhage: cost-effectiveness implications of endoscopic therapy.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Jan 1999 
 - 44-50 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0270-9139 
<br/><br/><label>Standard No.: </label>10.1002/hep.510290141  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cost-Benefit Analysis<br/>Direct Service Costs<br/>Double-Blind Method<br/>Emergency Treatment<br/>Esophageal and Gastric Varices--complications<br/>Female<br/>Follow-Up Studies<br/>Hemorrhage--economics<br/>Hemostasis, Endoscopic--economics<br/>Humans<br/>Ligation--economics<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Recurrence<br/>Sclerotherapy--economics<br/>Treatment Outcome